Evidence map›Paper›PMID 33672724›Full record

ArticleInternational journal of molecular sciences2021

Role of Shear Stress and tPA Concentration in the Fibrinolytic Potential of Thrombi.

Claire S Whyte, Hadj Ahmed Mostefai, Kim M Baeten, Andrew J Lucking, David E Newby, Nuala A Booth, Nicola J Mutch

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Plg-RMolecular medicine (Cambridge, Mass.) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Fibrinolysis: an illustrated review.Research and practice in thrombosis and haemostasis · 2023
    Review
  13. Review
  14. Article
  15. "Going with the flow" in modeling fibrinolysis.Frontiers in cardiovascular medicine · 2022
    Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Claire S WhyteAberdeen Cardiovascular and Diabetes Centre, Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, Scotland, UK.ORCID 0000-0001-8127-6102
Hadj Ahmed MostefaiAberdeen Cardiovascular and Diabetes Centre, Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, Scotland, UK.
Kim M BaetenAberdeen Cardiovascular and Diabetes Centre, Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, Scotland, UK.ORCID 0000-0001-7745-3882
Andrew J LuckingCentre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4SB, Scotland, UK.
David E NewbyCentre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4SB, Scotland, UK.
Nuala A BoothAberdeen Cardiovascular and Diabetes Centre, Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, Scotland, UK.
Nicola J MutchAberdeen Cardiovascular and Diabetes Centre, Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, Scotland, UK.
University of Aberdeen · GBUniversity of Edinburgh · GB

Funding

British Heart Foundation CH/09/002British Heart Foundation CH/09/002/26360British Heart Foundation FS/11/2/28579British Heart Foundation PG/04/131/18118British Heart Foundation PG/08/127/2651British Heart Foundation PG/15/82/31721British Heart Foundation PG/20/17/35050British Heart Foundation RE/18/5/34216British Heart Foundation RG/16/10/32375Wellcome Trust WT103782AIA
6 · The paper itself

Abstract

The resolution of arterial thrombi is critically dependent on the endogenous fibrinolytic system. Using well-established and complementary whole blood models, we investigated the endogenous fibrinolytic potential of the tissue-type plasminogen activator (tPA) and the intra-thrombus distribution of fibrinolytic proteins, formed ex vivo under shear. tPA was present at physiologically relevant concentrations and fibrinolysis was monitored using an FITC-labelled fibrinogen tracer. Thrombi were formed from anticoagulated blood using a Chandler Loop and from non-anticoagulated blood perfused over specially-prepared porcine aorta strips under low (212 s

Indexed as

FibrinolysisShear StrengthStress, MechanicalAnimalsFibrinHumansPlasminogenPlasminogen Activator Inhibitor 1SwineThrombosisTissue Plasminogen ActivatorFibrinPlasminogenPlasminogen Activator Inhibitor 1Tissue Plasminogen Activatorfibrinolysisplasminogen activator inhibitor-1shearthrombitissue plasminogen activator

Identifiers

PMID33672724
PMCPMC7924342
OpenAlexW3129613495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.